# Bladder Cancer and Neoadjuvant Chemotherapy Efficiency Before Cystectomy

> **NCT06294054** · — · UNKNOWN · sponsor: **University Hospital, Rouen** · enrollment: 707 (estimated)

## Conditions studied

- Bladder Cancer
- Genomic Instability

## Interventions

- **COMBINATION_PRODUCT:** neoadjuvant chemotherapy with cisplatine

## Key facts

- **NCT ID:** NCT06294054
- **Lead sponsor:** University Hospital, Rouen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-04-01
- **Primary completion:** 2026-03-31
- **Final completion:** 2026-03-31
- **Target enrollment:** 707 (ESTIMATED)
- **Last updated:** 2024-03-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06294054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06294054, "Bladder Cancer and Neoadjuvant Chemotherapy Efficiency Before Cystectomy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06294054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*